Name: AARD Balance Sheet - Aardvark Therapeutics Assets & Debt | Ledgeburg
Creator: Ledgeburg
License: https://creativecommons.org/licenses/by/4.0/
Keywords: Total Assets, Current Assets, Cash and Equivalents, Total Liabilities, Long-term Debt, Short-term Debt, Shareholders Equity, Working Capital, Book Value Per Share

JavaScript is disabled. Some features may not work properly. For the best experience, please enable JavaScript in your browser.

AARD - Aardvark Therapeutics, Inc.

USD | NASDAQ | Healthcare

AARD Balance Sheet - Aardvark Therapeutics Assets & Debt | Ledgeburg

(in millions of USD)	Q1 FY 26	Q4 FY 25	Q3 FY 25	Q2 FY 25	Q1 FY 25	Q4 FY 24	Q3 FY 24	Q2 FY 24	Q1 FY 24	Q4 FY 23
Cash And Short Term Investments
Cash And Equivalents	62.4	47.1	39.3	26.0	26.5	61.6	-	-	-	-
Restricted Cash	-	-	-	-	-	-	-	-	-	-
Short Term Investments	28.8	63.0	87.1	115.8	124.8	12.0	-	-	-	-
Cash And Short Term Investments	91.2	110.0	126.4	141.8	151.3	73.7	-	-	-	-
Receivables
Accounts Receivable	-	-	-	-	-	-	-	-	-	-
Current Assets
Inventory	-	-	-	-	-	-	-	-	-	-
Prepaid Expenses	2.4	1.9	2.9	2.9
Non-Current Assets
Property, Plant & Equipment Gross	-	-	-	-	-	-	-	-	-	-
Accumulated Depreciation	-	-	-
Current Liabilities
Accounts Payable	4.5	2.1	4.4	5.1	2.6	2.3	-	-	-	-
Short Term Debt	-	-	-	-
Non-Current Liabilities
Long Term Debt	-	-	-	-	-	-	-	-	-	-
Operating Lease Liabilities Non-Current	-	-	0.1
Common Equity
Common Stock	0.0	0.0	0.0	0.0	0.0	0.0	-	-	-	-
Additional Paid In Capital	-	-	-	-
Supplementary Data
Total Debt	-	-	-	-	-	-	-	-	-	-
Net debt	-	-	-	-

Source: SEC EDGAR company filings. Figures as reported (US GAAP)

(in millions of USD)	FY2025	FY2024	FY2023
Cash And Short Term Investments
Cash And Equivalents	47.1	61.6	-
Restricted Cash	-	-	-
Short Term Investments	63.0	12.0	-
Cash And Short Term Investments	110.0	73.7	-
Receivables
Accounts Receivable	-	-	-
Current Assets
Inventory	-	-	-
Prepaid Expenses	1.9	0.5	-
Other Current Assets	-	-	-
Assets Held For Sale	-
Non-Current Assets
Property, Plant & Equipment Gross	-	-	-
Accumulated Depreciation	-	-	-
Property,Plant & Equipment Net	-	-	-
Long Term Investments
Current Liabilities
Accounts Payable	2.1	2.3	-
Short Term Debt	-	-	-
Deferred Revenue Current	-	-	-
Operating Lease Liabilities Current
Non-Current Liabilities
Long Term Debt	-	-	-
Operating Lease Liabilities Non-Current	0.0	0.4	-
Deferred Revenue Non-Current	-	-	-
Deferred Tax Liabilities
Common Equity
Common Stock	0.0	0.0	-
Additional Paid In Capital	-	-	-
Retained Earnings	(115.9)	(58.3)	-
Accumulated Other Comprehensive Income
Supplementary Data
Total Debt	-	-	-
Net debt	-	-	-
Working Capital	101.3	69.2	-
Book Value	106.6

Source: SEC EDGAR company filings. Figures as reported (US GAAP)